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Poly(3-hydroxybutyrate): Promising biomaterial for bone 
tissue engineering
Poly(3-hydroxybutyrate) is a natural polymer, produced by 
different bacteria, with good biocompatibility and biode gra-
dability. Cardiovascular patches, scaffolds in tissue engi-
neering and drug carriers are some of the possible biome-
dical applications of poly(3-hydroxybutyrate). In the past 
decade, many researchers examined the different physico-
chemical modifications of poly(3-hydroxybutyrate) in order 
to improve its properties for use in the field of bone tissue 
engineering. Poly(3-hydroxybutyrate) composites with hydro-
xy apatite and bioglass are intensively tested with animal 
and human osteoblasts in vitro to provide information about 
their bio com patibility, biodegradability and osteoinductivity. 
Good bone regeneration was proven when poly(3-hydroxy-
butyrate) patches were implanted in vivo in bone tissue of 
cats, mini pigs and rats. This review summarizes the recent 
reports of in vitro and in vivo studies of pure poly(3-hydroxy-
butyrate) and poly(3-hydroxybutyrate) composites with the 
emphasis on their bioactivity and biocompatibility with 
bone cells.




A biomaterial can be defined as a natural or synthetic material suitable for interacting 
with biological systems, with a function to treat, augment or replace any tissue or organ 
(1). Biodegradable and biocompatible natural or synthetic polymers are referred to as “bioma-
terials” (2). Biomaterials for bone tissue engineering should fulfill the following require-
ments (3−5):
•  Mechanical strength to withstand hydrostatic pressure. Young’s modulus of cortical 
bone is between 15 and 20 GPa and that of cancellous bone is between 0.1 and 2 GPa. 
Compressive strength varies between 100 and 200 MPa for cortical bone, and between 
2 and 20 MPa for cancellous bone (5). The large variation in mechanical properties 
and geometry makes it difficult to design an “ideal” bone scaffold.
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•  Biocompatibility to induce new tissue formation without inflammation.
•  Surface properties that suit osteogenic cells. For growth, proliferation and diff eren-
tia tion of cell hierarchical structure is crucial.
•  Osteoinductivity to promote migration of osteogenic cells and to stimulate diff eren-
tiation. An important role in osteoinductivity is played by chemical composition of 
the scaffold, porosity, surface properties and nano/micro topography.
•  Porosity to allow cell ingrowth and neovascularization. Porosity is essential for dif-
fusion of nutrients and for removal of metabolic wastes resulting from cellular ac-
tivity. Pore size should be at least 100 μm in diameter for successful diffusion of 
essential nutrients and oxygen. However, pore size in the range of 200 to 350 μm 
was found to be optimal for bone tissue in-growth (4, 5).
•  Vascularity to stimulate angiogenesis. Lack of vasculature leads to ischemia and cell 
apoptosis.
•  Bioresorbability after scaffold degradation to allow new bone tissue to grow. The 
scaffold should degrade at a controlled resorption rate, creating space for the new 
bone tissue to grow. Degradation products should not cause inflammation to the 
surrounding tissue (3−5).
Biodegradable and biocompatible polyesters are being investigated worldwide for 
pharmacological, biomedical and environmental purposes (6). Polyhydroxyalkanoates 
(PHA) are natural polyesters produced by bacteria as intracellular carbon and energy 
sources when essential nutrients are limited and carbon is available (7). Poly(3-hydroxy-
butyrate) (PHB) is one of the best-known polymers of the PHA family (8). PHB is a homo-
polymer of (R)-3-hydroxybutyrate units (Fig. 1). Its molecular mass can range from 200 to 
up to 20,000 (9, 10).
Molecular mass of PHB is a very important feature to consider in PHB applications, 
because it determines the mechanical properties of the polymer and, in turn, the final ap-
plication. Mechanical and thermal properties of PHB are high crystallinity (60−70 %), high 
melting temperature (175 °C), good tensile strength (30−35 MPa) and appropriate elasticity 
modulus (3 GPa) (11, 12). It is a promising material for biomedical applications because it 
is a natural, renewable, biodegradable and biocompatible thermoplastic (13). PHB decom-
poses to 3-hydroxybutyric acid, which is also normally found in human blood (14). 3-Hy-
droxybutyric acid increases calcium influx in cultured cells and suppresses their death 
(15). In nature, PHB is degraded by the action of non-specific lipases and esterases. There-
fore, lipases and esterases are presumably the enzymes that degrade PHB implants and 
their medical devices in vivo (16). Furthermore, sterilization of PHB-based materials does 
not affect the mechanical or chemical properties (17). Nevertheless, for packing materials, 
tissue engineering, and other specific applications, the physical and mechanical properties 
Fig. 1. Chemical structure of poly(3-hydroxybutyrate) (PHB).
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of PHB need to be diversified and improved. The main limitation, besides its relatively 
high cost of production, is the lack of bioactivity (12, 16). In addition, hydrophobic PHB 
needs to have a hydrophilic character for biomedical applications (2). Porosity, surface 
properties and, in part, mechanical strength are determined by processing conditions 
when preparing a scaffold for bone tissue engineering (4). PHB, like all PHAs, is sensitive 
to processing conditions, especially to temperature and shear and exhibits a very narrow 
processing window (12). For example, PHBs of low molecular mass (< 1 ́  103) are character-
ized by early thermal degradation, near their melting temperature (above 180 °C) (12, 18). 
Additives, blends and composites are mostly used to overcome these problems (8). Further-
more, PHB is soluble in few solvents, i.e., chloroform, dichloromethane and dimethyl 
 formamide; therefore, the formation of composite structures is challenging (19). As already 
mentioned, thermal molding is also difficult, since above 150 °C most of the PHA-based 
polymers break down to fatally toxic trans-crotonic acids. Taken together, PHB limitations 
such as mechanical properties, high production cost, limited functionalities, incompatibility 
with conventional thermal processing techniques, susceptibility to thermal degradation 
have limited effective application of PHB and these are still challenges to be addressed in 
the future. In the present review, we report on the current biomedical applications of PHB 
in bone tissue engineering with the emphasis on physicochemical modifications of PHB 
and in vitro and in vivo experiments.
BIOMEDICAL APPLICATIONS OF PHB IN BONE TISSUE ENGINEERING
Physicochemical modifications of PHB in the field of bone tissue engineering
Numerous studies investigate the use of PHB in bone tissue engineering (20). Bone 
tissue engineering is a research area where bone replacements are being developed and 
clinically tested in cases of orthopedic defects, bone tumors, and in maxillofacial, neck and 
head surgery (11). It provides solutions for generating new bone tissue with good func-
tional and mechanical qualities (21). Recent work in this field has been focused on the 
development of three-dimensional porous scaffolds loaded with specific living cells to 
provide tissue regeneration in a natural way. According to Hutmacher (22), a scaffold 
should satisfy the following criteria: (i) to be bioresorbable and biocompatible with a con-
trollable degradation and resorption rate to match cell/tissue growth in vitro/vivo; (ii) to 
have suitable surface chemistry for cell attachment, proliferation and differentiation; (iii) 
to be three-dimensional and highly porous to enable cell growth, flow transport of nutri-
ents and metabolic waste; (iv) to have proper mechanical properties like the tissue at the 
site of implantation. In addition to being biocompatible and biodegradable, PHB-based 
biomaterials are piezoelectric and thus may promote bone growth in vivo (23). PHB has the 
disadvantages of having low compressive modulus and poor bioactivity. Ceramic implants, 
on the other side, are stiffer but they are often fragile and known to fracture during clinical 
use (24). Therefore, a combination of PHB with a bioactive ceramic is expected to improve 
the mechanical and chemical properties of composites (24).
Bone is considered to be a composite material consisting of nanosized calcium phos-
phates (CaP) embedded in a collagen-rich organic matrix permeated with pores filled with 
liquids (24). Most similar to the mineral part of the bone is hydroxyapatite [Ca10(PO4)6(OH)2, 
HA] (24). Its chemical similarity to the inorganic bone materials makes it biocompatible, 
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modifiable by the osteoclasts and slowly biodegrading in situ (25, 26). As HA is a porous 
material, ingrowth of capillaries and other vessels is possible (27). In this way, the cells in 
the scaffold are supplied with metabolic oxygen and nutrients. Wang et al. (28) showed that 
growth and alkaline phosphatase activity of osteoblasts were better on PHB-HA scaffolds 
compared to PHB scaffolds. According to Hayati et al. (11), 15 % (m/m) of HA nanoparticles 
was the best content for incorporation of HA in a PHB matrix, while Shishatskaya et al. (29) 
obtained the best results for growth and differentiation of osteoblasts on PHB/HA com-
posites containing 10 and 20 % HA. Sadat-Shojai et al. (24) have proven that 15 % (m/m) of 
HA nanoparticles stimulate cell proliferation and cell differentiation. HA nanoparticles 
covering the PHB fiber surface enhanced differentiation of mesenchymal stromal cells 
toward the osteoblast phenotype (30−32). Titanium oxide (TiO2) showed no effect on osteo-
blast growth when TiO2 was added to PHB/HA scaffolds (34). The above mentioned studies 
also reported improved mechanical properties of PHB/HA scaffolds (3, 11, 24, 32). Bioglass 
with osteoconduction and osteostimulation properties is another bioactive inorganic 
phase used in making composites with PHB. It has been shown that optimal concentration 
of nanobioglass (7.5 %, m/m) in nanocomposite scaffolds significantly improves cell proli-
feration and induces better cytocompatibility and osteoconductivity compared to PHB 
scaffolds (35). Bioactivity of PHB composites with bioglass (10 %, m/m) was also proven by 
Misra et al. (36). Nanobioglass was shown to improve mechanical strength and increase the 
scaffold degradation kinetics (35, 36). The latest study evaluated the response of bone to 
novel biodegradable polymeric composite implants made of PHB and Herafill® (37). Herafill® 
is a composite made of calcium sulfate (CaSO4), calcium carbonate (CaCO3) and glycerol 
tripalmitate (37). It was clinically used as an alternative bone substitute material with 
proven osteoconductivity (38). The highest value of bone accumulation was observed 
around the implant of the PHB composite with 30 % of Herafill®; however, the authors 
could not give any clear recommendation regarding the use of PHB composite materials 
as biodegradable implants for bone fixation (37). As a natural polysaccharide, chitosan is 
known for its biocompatibility and therefore PHB/HA/chitosan composite scaffolds (39) 
and PHB/ biophasic calcium phosphate/chitosan membranes (40, 41) were tested for their 
use in bone tissue engineering. Chitosan reduced crystallinity and improved surface 
proper ties and biological activity of scaffolds (3, 20, 39). Most recent studies report modifi-
cations of PHB with poly(ε-caprolactone) (PCL) and sol-gel silica (42), PCL and bioglass (43), 
cellulose acetate (44), zwitterionic poly(4-vinylpiridine) hydrophilic groups on poly(octa-
decylacrylate) blocks (45) and natural anionic polysaccharides (46). Sol-gel silica enhanced 
the stiffness and strength of PHB/PCL fibers (42), while PHB/cellulose acetate scaffolds 
had three times higher degradation rates compared to PHB scaffolds (44). Incorporation 
of natural anionic polysaccharides into PHB decreased its crystallinity, enhanced surface 
hydrophilicity, reduced brittleness and enhanced degradation of polymer blend films 
(46). All five studies have proven cell growth and proliferation on those scaffolds; never-
theless, further research is needed. Physicochemical modifications of PHB are presented 
in Table I.
In vitro biocompatibility of PHB on bone cells
In vitro tests of PHB and PHB composite scaffolds were performed with osteoblasts of 
different organisms (16). Polymeric materials, bone cell types and methods of analysis of 
biocompatibility tests in vitro are reported in Table II. Wang et al. (28, 48) evaluated the 
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 attachment, proliferation and differentiation of rabbit bone marrow cells on PHB and PHB-
HA scaffolds. PHB-HA scaffolds were shown to be a suitable biomaterial for rabbit bone 
marrow cell attachment, proliferation and differentiation (28, 32, 48). Several studies estab-
lished in vitro tests of PHB scaffolds on murine osteoblasts (6, 7, 29). Sadat-Shojai et al. (24) 
showed a significant increase in proliferation and differentiation of murine osteoblasts on 
PHB/HA composites. A novel study by Zhijiang et al. (44) demonstrated that the PHB/cel-
lulose acetate blend nanofiber scaffolds have better biocompatibility and higher prolifera-
tion rate of murine osteoblasts than a pure PHB film. In their recent studies, Sadat-Shojai 
et al. describe a new strategy for fabrication of bone scaffolds using electrospun nano-HA/
PHB fibers (33) and electrospun nano-HA/PHB and protein gels (49). According to their 
results, mechanical properties of the construct were good and murine osteoblasts inside 
the scaffolds were viable. Since cells rapidly proliferate on PHB scaffolds, Peng et al. (50) 
Table I. Physicochemical modifications of PHB in the field of bone tissue engineering





























HA/TiO2 50 76 Cell binding  34 






























CA 10, 20, 30, 40 86−81 Cytocompatibility  44 
4VP-r-ODA Not reported 36 Bioactivity  45 
Natural anionic 
polysaccharides 5, 10, 20, 30, 50 Not reported Bioactivity  46 
Magnesium discs 
with PHB coating − Not reported Bioactivity  47 
CA − cellulose acetate,  CP − calcium phosphate, PCL − poly(ε-caprolactone), 4VP-r-ODA − zwitterionic poly(4-vinyl-
piridine) hydrophilic groups on poly(octadecylacrylate) blocks
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Table II. Polymeric materials, bone cell types and methods of analysis of biocompatibility tests in vitro
Polymeric material Bone cell type Methods of analysis Reference
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tested the risk of carcinogenicity. Their results confirmed no tumor induction when pro-
liferating rat osteoblasts were grown on PHB films. Another study on fibroblasts has proven 
that PHB is not genotoxic and did not alter the expression of the proto-oncogenes and 
anti-apoptotic genes analyzed in the study (51). Wang et al. (52) proved proliferation of rat 
osteoblasts on various PHA films; however, the lowest percentage of apoptotic cells was 
seen when cells were grown on PHB. Tai et al. (40) developed asymmetric membranes of 





































Alizarin red staining 
 43 








Alamar blue assay − quantifying the metabolic activity; Alizarin red staining − in vitro calcium containing deposits 
and mineralized matrix analysis; ALP assay − alkaline phosphatase activity assay; BrdU incorporation − staining 
of 5-bromodeoxyuridine, evaluation of cell proliferation; Calcein-AM/EthD-1 live/dead kit − calcein-AM/ethidium 
homodimer-1, visualization of cell viability; CCK-8 − cell counting kit-8; DAPI − 4′,6-diamidino-2-phenylindole; 
DNA quantification − determination of cell proliferation; ECM − extracellular matrix; ELISA − enzyme-linked 
immunosorbent assay; MTT assay − 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide, in vitro 
mitochondrial metabolic activity test; MTS assay − 3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethophenyl)-2(4-
sulfofenyl)-2H-tetrazolium, in vitro cells viability test; Phalloidin assay − in vitro immunofluorescence analysis; 
qRT-PCR − quantitative real-time-polymerase chain reaction, in vitro gene expression test; SEM − scanning electron 
microscopy; Trypan blue staining − quantification of viable cells
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PHB and biphasic calcium phosphate/chitosan and showed increased proliferation of rat 
primary osteoblasts on membranes. When PHB/calcium phosphate/chitosan composite 
films were enzymatically degraded, significant proliferation of murine osteoblasts was 
observed (41).
Since PHB is a candidate for use in human bone engineering, numerous studies are 
aimed at assessing biocompatibility using human osteoblasts. Hayati et al. (11) and Saadat 
et al. (31) confirmed the biocompatibility of PHB/HA composite scaffolds using the human 
osteosarcoma cell line (MG-63). Morphology of the attached MG-63 cells in direct contact 
with the scaffolds demonstrated appropriate cell-scaffold interaction. Similar results on 
the appropriate cell-scaffold interaction were obtained when MG-63 cells were grown on 
PHB composite scaffolds with bioglass nanoparticles (35, 36). MG-63 cells showed good 
osteoblastic differentiation on both PHB/PCL/sol-gel derived silica hybrid scaffolds (42) as 
well as on PHB/PCL/bioglass hybrid scaffolds (43). Differentiation of human bone marrow 
cells toward osteoblasts was studied and proven on novel acrylic bone cement combining 
PHB and bioactive glass (23). Ramier et al. (30) developed different types of PHB-based 
nanofibrous scaffolds and tested them with human mesenchymal stromal cells (hMSCs). 
Faster cell development was recorded on gelatin-containing scaffolds, whereas HA 
nanoparticles covering the scaffold surface enhanced differentiation of hMSCs towards 
the osteoblast phenotype. Rentsch et al. (53) seeded hMSCs on PHB scaffolds coated with 
extracellular matrix components type I collagen and chondroitin sulfate. Their study demon-
strated the positive effect of collagen I and chondroitin sulfate on proliferation and dif-
ferentiation of hMSCs. Karahaliloğlu et al. (54) used a NaOH-based alkaline treatment to 
create PHB membranes and proved increased proliferation of human osteoblasts on the 
NaOH-treated PHB membranes. Furthermore, NaOH-treated PHB surfaces inhibited 
Staphylococcus aureus growth compared to the untreated PHB surface. Pourmollaabbassi et 
al. (34) evaluated the growth and adhesion of human osteoblasts on PHB/HA/TiO2 scaf-
folds. They observed no effect of TiO2 on cell growth and, therefore, concluded that HA 
alone affected the growth and cell osteoblast adhesion on the scaffold. A novel study by 
Rozila et al. (55) evaluated the osteogenic potential of human adipose-derived stem cells 
(HADSCs) when co-cultured with human osteoblasts (HOBs) on electrospun PHB/HA 
scaffolds. The highest alkaline phosphatase (ALP) production and calcium deposition 
were shown in the monoculture of HOBs on PHB/HA scaffolds. Nevertheless, co-culture 
Table III. Polymeric materials and places of PHB implantations in animal bone
Polymeric material Place of implantation Reference
PHB patches Anterior skull base of minipigs  57 
PHB/HA composites Cat femur  59 
PHB composites with zirconium 
dioxide and crystalline Mg Rat femur  60 
PHB patches Surgically created defects on male rats’ cranium  58 
PHB composites with zirconium 
dioxide and Herafill® Growing rats’ femur  37 
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of HADSCs/HOBs 1:1 on PHB/HA scaffold showed significantly higher cell proliferation, 
production of ALP, extracellular mineralization and osteogenic-related gene expression 
compared to other tested groups. The authors concluded that the good interaction of HAD-
SCs and HOBs enhanced the differentiation of stem cells. However, osteogenesis is pro-
moted not only by cell-cell contacts, but also by the bioactive composition of the PHB/
HA-based scaffold (55). In the latest study, the growth of human osteosarcoma cells was 
determined after PHB surface was treated with a KrF laser (56). The proposed method was 
shown to be suitable for certain modifications in surface properties of the PHB scaffold.
In vivo studies of PHB in bone
The following level in evaluating biocompatibility of polymer scaffolds is to observe 
the response when they are implanted into tissue (Table III).
Bernd et al. (57) used PHB patches to cover anterior skull base defects in minipigs. The 
results showed increasing closure of bone defect with time. After 9 months, the anterior 
skull base defect was completely closed. Analysis of biodegradation detected a continuous 
breakdown of PHB. Gredes et al. (58) studied PHB patches after implantation in surgically 
created defects on the cranium of adult rats. No sign of cellular inflammation or PHB rejec-
tion was detected. Twelve weeks after surgery, bone formation was proven in all PHB-
treated cavities. Furthermore, a pronounced development of blood vessels was observed. 
However, the authors suggested that the osteoinductive properties of PHB should be fur-
ther analyzed (58). On the other hand, Alves et al. (59) observed a chronic local inflamma-
tory response when PHB/HA composites were implanted in cats. Brigham and Sinskey (16) 
summarized early in vivo biocompatibility studies of different PHA matrices and showed 
that post-traumatic inflammation following surgical procedures was common around 
PHA implants. Celarek et al. (60) designed a study to evaluate PHB composites with zirco-
nium dioxide, crystalline magnesium alloys and MgZnCa bulk metallic glasses as possible 
candidates for bone implants. PHB composites were implanted in rats’ femora. According 
to the authors, mechanical properties and degradation of studied materials were unsatis-
factory. Meischel et al. (37) evaluated the response of bone to PHB composite implants in the 
femora of growing rats. PHB composites were made with zirconium dioxide and Herafill®. 
After 36 weeks in vivo, no significant degradation in any of the implants was found. Compo-
sites containing Herafill® were the most attractive for bone cells with regard to accumulation 
and growth of bone cells. 
As shown above, the results obtained by the in vivo studies demonstrated that the 
PHB-based systems are promising candidates for bone repair. Unfortunately, only few 
examples of in vivo studies involving PHB and PHB scaffolds are present in the literature 
(37, 57−60). Therefore, more research is needed to confirm and validate the possibility of 
using this polymer in biomedicine.  
CONCLUSIONS AND OUTLOOK
The field of bone tissue engineering has progressed rapidly over the past years. Use 
of natural polymers seems promising in the bone regeneration process. PHB is a bacteri-
ally derived polymer known to be biocompatible and biodegradable. Due to its poor me-
chanical properties, PHB needs to be modified in order to be useful in biomedical applica-
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tions. Different physicochemical modifications of PHB in the field of bone tissue 
engineering are proposed to improve the PHB properties. Most commonly used modifiers 
are HA, bioglass and chitosan in combination with calcium phosphate. All three modifiers 
improved mechanical properties of tested scaffolds compared to neat PHB. Furthermore, 
the use of HA, bioglass, cellulose acetate or natural anionic polysaccharides as PHB modi-
fiers decreased the degradation rate of tested scaffolds. Enhanced bioactivity is a common 
feature of all modifiers reported in this review. On the other hand, mechanical properties 
of human bones vary depending on the species, race, sex and age. Regional variation in 
mechanical properties is also observed within the same body. Therefore, scaffolds will 
need to be fabricated accordingly to match the mechanical properties of each respective 
application. To our knowledge, no study has compared the mechanical properties, osteo-
inductivity and biodegradability of PHB composites when implanted in male and female 
test animals yet.
Biocompatibility evaluations conducted under different experimental conditions and 
using various cell lines highlighted the good in vitro and in vivo biocompatibility of PHB 
and PHB composites. Furthermore, PHB/HA composites were proven to enable differen-
tiation of human stem cells toward osteoblast phenotype. Thus, the conclusion was made 
that PHB/HA scaffolds promote osteogenesis. Studies proved HA to be the optimal modi-
fier for PHB, since PHB/HA scaffolds were shown to have good mechanical properties, 
optimal osteoinductivity, suitable porosity and, finally, the desired rate of degradability. 
In vivo studies showed new bone formation around PHB patches but slow degradation of 
PHB implants. Sufficient vascularization of implants would certainly improve cell growth 
and enable faster degradation of biomaterial. Nevertheless, vascularization in vivo is de-
pendent on scaffold structure, namely, pore size and interconnectivity of pores. Also, local 
delivery of angiogenic growth factors would accelerate vascularization of an implanted 
graft. Angiogenic growth factors may also be incorporated into the scaffold. The major 
limitation of in vivo results is the small number of such studies; therefore, further research 
is needed. To our knowledge, PHB has not received approval for uses in biomedicine either 
by the European Medicines Agency, the Food and Drug Administration or Japanese Phar-
maceuticals and Medical Devices Agency; therefore, no clinical trials have been carried out 
to date.
Although many promising results have been achieved, further research needs to be 
carried out before PHB and PHB composites can be commercialized for biomedical appli-
cations. Challenges for the future are cost reduction of the production and extraction of 
PHB, optimization of PHB regarding all requirements for bone tissue engineering scaf-
folds and, finally, in vivo studies to confirm the usability of PHB composites for bone tissue 
engineering.
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